Charlotte Kirby Charlotte Kirby

Angels on the side of PharmEnable in £1.8m round

PharmEnable, a Cambridge drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, has closed a £1.8 million seed round.

Read More
Charlotte Kirby Charlotte Kirby

Featurespace prepares move to Cambridge Science Park

Featurespace, whose AI technology enables financial institutions worldwide to detect and prevent fraud and financial crime, is in the process of moving its UK headquarters to the iconic Cambridge Science Park.


Read More
Charlotte Kirby Charlotte Kirby

The future of digital contact tracing

So far in the show we’ve talked covid testing and monitoring. Now to tracking and tracing the infection. Last week, Germany launched what it claims is the world’s best app for covid contact tracing. We were expecting ours in May, but so far it’s failed to materialise. Last week we got the lowdown on this from University of Strathclyde security engineer Greig Paul...

Read More
Charlotte Kirby Charlotte Kirby

Paragraf goes nuclear with CERN partnership

University of Cambridge spin-out Paragraf is working with the Magnetic Measurement section at CERN, the European Organisation for Nuclear Research, to demonstrate the potential benefits of the company’s graphene sensor.

Read More
Charlotte Kirby Charlotte Kirby

Cambridge leads €10.3m power applications venture

A Cambridge company pioneering nextgen Gallium Nitride power modules for a range of industries has been chosen to lead a €10.3 million European project designed to accelerate critical uses for the technology.

Read More